In conclusion, these findings suggest a regulatory mechanism in which TRPM7 modulates cellular metabolic shifts in ovarian cancer by influencing the AMPK/HIF-1α signaling pathway, highlighting its role as a key mediator in metabolic reprogramming. The gene discussed is TRPM7; the disease is ovarian cancer.